First in the Area to Offer Promising Hypertension Treatment

CHESAPEAKE, VA – For adults struggling to manage high blood pressure despite medication and lifestyle changes, the daily effort can be frustrating and feel like a losing battle. Chesapeake Regional Medical Center is introducing new hope by becoming the first in the region to successfully perform a groundbreaking, minimally invasive procedure for resistant hypertension, offering a powerful new option for patients.

A New, Proven Approach to Managing Hypertension
The cardiovascular team recently completed the region's first three renal denervation (RDN) procedures using Medtronic's innovative Symplicity Spyral™ system. This one-time, hour-long procedure targets overactive nerves connected to the kidneys that can contribute to high blood pressure. Using precisely controlled radiofrequency energy, the system safely disrupts these nerve signals to help lower blood pressure. Globally, over 30,000 patients have already been treated with this technology.

Convenience and Control for Modern Patients
Designed for today's busy lifestyles, the RDN procedure is typically performed on an outpatient basis, allowing patients to return home the same day. Studies show that 30% of patients would be willing to consider an interventional procedure like this rather than add another daily medication to their routine. It is ideal for patients with uncontrolled hypertension who, in partnership with their doctor, decide an interventional option is the right next step after exploring lifestyle modifications and medical therapy.

Chesapeake Regional Healthcare is committed to bringing leading-edge, patient-centered solutions to Hampton Roads. Individuals interested in learning whether the Symplicity™ blood pressure procedure is right for them are encouraged to speak with their primary care provider or a Chesapeake Regional cardiologist to discuss their options.

###